Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 107Gliosarcoma 48Glioma 41Brain Neoplasms 38Astrocytoma 38Central Nervous System Neoplasms 30Oligodendroglioma 27Medulloblastoma 15Melanoma 14Neuroblastoma 13Ependymoma 11Neoplasms 10Familial ependymoma 8Choroid Plexus Neoplasms 8Unspecified Adult Solid Tumor, Protocol Specific 6Sarcoma 6Optic Nerve Glioma 6Neuroectodermal Tumors, Primitive 6Neoplasm Metastasis 6Sarcoma, Ewing 5Recurrence 5Rhabdoid Tumor 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Osteosarcoma 4Lymphoma 4Glioma, Subependymal 4Spinal Cord Neoplasms 3Rhabdomyosarcoma 3Pinealoma 3

Interventions

entinostat 3Carboplatin 3osimertinib 2Pemetrexed 2pembrolizumab 1exemestane 1Tyrosine Kinase Inhibitors 1Temozolomide 1Paclitaxel 1Indocyanine Green 1Erlotinib Hydrochloride 1Dasatinib 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Lung Diseases × Temozolomide × Clear all
NCT00249964 2016-01-20

Combination Paclitaxel, Carboplatin and Temozolomide

New Mexico Cancer Research Alliance

Phase 1 Completed
15 enrolled

Lung Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡